AI’s Energy Crunch Has Investors Searching for Next IPO Winners
THE SO WHAT
Capital is rotating from pure AI names into the power stack—Wall Street is betting billions on grid, generation, and cooling firms whose tech isn’t fully proven yet. If you’re planning large-scale AI deployment, treat energy availability and pricing as a first-class strategic constraint, not a line item procurement will sort out later.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechIt’s Possible to 3D Print an Entire Outfit Now. ‘Should You?’ Is Another Question
End-to-end 3D printed clothing is a reminder that consumer fabrication is creeping up the value chain from trinkets to textiles. For brands, the risk isn’t everyone printing their own wardrobe tomorrow—it’s niche communities proving new supply chains viable long before incumbents notice.
Deep & Emerging TechFBI says Russian intelligence hackers have a new trick for reading your Signal messages, and it works even after you change phones
End-to-end encryption doesn’t help if attackers phish your Signal backup recovery key once and keep reading forever. Treat recovery flows and key storage as crown-jewel assets—lock them behind hardware keys, admin policies, and user training, not just app defaults.
Deep & Emerging TechA look at South Korea's four vocational "meister" schools that train students to work in semiconductor manufacturing, leading to jobs at Samsung and SK Hynix
South Korea is running a dedicated semiconductor talent pipeline at the high-school level—direct to Samsung and SK Hynix fabs. If you rely on advanced manufacturing, you’re competing not just on capex but on countries’ willingness to vocationalize entire career tracks around your industry.
Deep & Emerging TechThe fittest founder in the room got cancer. Here’s how he used AI to fight back.
A single patient piping labs, scans, wearables, and journals into Claude is a preview of what AI‑mediated care will look like long before hospitals standardize it. Health and wellness products that don’t assume an AI layer interpreting multimodal personal data will feel obsolete faster than their clinical evidence cycles change.